Drug Metabolism: The Importance of Child-Pugh Classification for Staging Hepatic Impairment

<p>This episode discusses the Child-Pugh scale to assess hepatic impairment. It also covers the FDA's position on the inclusion of drug metabolism data for various Child-Pugh stages and cirrhosis.</p> <p>Faculty: Jonathan Meyer, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099"> <strong>Learn more about Premium Membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/use-of-psychotropics-in-patients-with-hepatic-issues-2582?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099"> <strong>Earn 1 CME: Use of Psychotropics in Patients With Hepatic Issues</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/the-importance-of-child-pugh-classification-for-staging-hepatic-impairment-2582-5009?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099"> <strong>The Importance of Child-Pugh Classification for Staging Hepatic Impairment</strong></a></li> </ul>